April 29, 2011
New Circular on Drug Registration
Managing Intellectual Property

Circular 22/2009/TT-BYT issued by the Ministry of Health, effective May 24, 2010, has clarified certain issues related to intellectual property rights and drug marketing approval in Vietnam. The Circular emphasizes that the applicant for marketing approval for a drug shall be responsible for any infringement of IPRs used on or in relation to the drug. Consequently, proof of IP cleanness for a drug, such as search reports, registration certificates, or application acceptance decisions, is no longer required by the Drug Administration of Vietnam for obtaining drug marketing approvals.

Related Professionals
Dung Thi Kim Vu
+84 24 3772 5554
Dzung Duy Nguyen